Name: Latest research reports of Divi's Laboratories Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Divi's Laboratories Ltd.
Rating: 4
Author: ICICI Securities Limited

Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Star

6108.0000 81.50 (1.35%)

NSE Apr 29, 2025 15:31 PM

New 52W High in past week

Volume: 640.1K

Divi's Laboratories Ltd.

16 Aug 2022

6108.00

1.35%

Recovery in API; margins hit

Accumulate: Divi's Laboratories Ltd.

Target

ICICI Securities Limited

Divi’s Laboratories’ (Divi’s) Q1FY23 performance was a mixed bag with revenue ahead of our estimates while margin was lower.

Divi's Laboratories Ltd. has gained 53.11% in the last 1 Year